Advances in Human Physiology Research

[1] Karn, V., Ahmed, S., Tsai, L.W., et al., 2021. Extracellular Vesicle-Based Therapy for COVID-19:

[2] Promises, Challenges and Future Prospects. Biomedicines. 9, 1373.

[3] DOI: https://doi.org/10.3390/biomedicines9101373

[4] Zhang, J., Kumar, S., Jayachandran, M., et al., 2021. Excretion of Urine Extracellular Vesicles Bearing Markers of Activated Immune Cells and Calcium/ Phosphorus Physiology Differ between Calcium Kidney Stone Formers and Non-Stone Formers. BMC Nephrol. 22, 204.

[5] DOI: https://doi.org/10.1186/s12882-021-02417-8

[6] Jayachandran, M., Yuzhakov, S.V., Kumar, S., et al., 2020. Specific Populations of Urinary Extracellular Vesicles and Proteins Differentiate Type 1 Primary Hyperoxaluria Patients without and with Nephrocalcinosis or Kidney Stones. Orphanet Journal of Rare

[7] Diseases. 15, 1-14. DOI: https://doi.org/10.1186/s13023-020-01607-1

[8] Xu, R., Rai, A., Chen, M., et al., 2018. Extracellular Vesicles in Cancer - Implications for Future Improvements in Cancer Care. Nature Reviews Clinical Oncology. 15, 617-638.

[9] DOI: https://doi.org/10.1038/s41571-018-0036-9

[10] Shetty, A.K., Upadhya, R., 2021. Extracellular Vesicles in Health and Disease. Aging and disease. 12, 1358-1362. DOI: https://doi.org/10.14336/AD.2021.0827

[11] Nagoor Meeran, M.F., Javed, H., Sharma, C., et al., 2021. Can Echinacea Be a Potential Candidate to Target Immunity, Inflammation, and Infection - The Trinity of Coronavirus Disease 2019. Heliyon. 7, e05990. DOI: https://doi.org/10.1016/j.heliyon.2021.e05990

[12] Nagoor Meeran, M.F., Sharma, C., Goyal, S.N., et al., 2020. CB2 Receptor-selective Agonists as Candidates for Targeting Infection, Inflammation, and Immunity in SARS-CoV-2 Infections. Drug Develoment Research. DOI: https://doi.org/10.1002/ddr.21752

[13] Xia, X., Yuan, P., Liu, Y., et al., 2021. Emerging Roles of Extracellular Vesicles in COVID-19, a Double-Edged Sword? Immunology. 163, 416-430. DOI: https://doi.org/10.1111/imm.13329

[14] Pocsfalvi, G., Mammadova, R., Ramos Juarez, A.P., et al., 2020. COVID-19 and Extracellular Vesicles: An Intriguing Interplay. Kidney and Blood Pressure Research. 45, 661-670.

[15] DOI: https://doi.org/10.1159/000511402

[16] Xia, X., Wang, Y., Huang, Y., et al., 2019. Exosomal MiRNAs in Central Nervous System Diseases: Biomarkers, Pathological Mediators, Protective Factors and Therapeutic Agents. Progress in Neurobiology. 183, 101694. DOI: https://doi.org/10.1016/j.pneurobio.2019.101694

[17] Ti, D., Hao, H., Tong, C., et al., 2015. LPS-Preconditioned Mesenchymal Stromal Cells Modify

[18] Macrophage Polarization for Resolution of Chronic Inflammation via Exosome-Shuttled Let-7b. Journal of Translational Medicine. 13, 1-14. DOI: https://doi.org/10.1186/s12967-015-0642-6

[19] Li, J.W., Wei, L., Han, Z., et al., 2019. Mesenchymal Stromal Cells-Derived Exosomes Alleviate Ischemia/ Reperfusion Injury in Mouse Lung by Transporting Anti-Apoptotic MiR-21-5p. European Journal of Pharmacology. 852, 68-76. DOI: https://doi.org/10.1016/j.ejphar.2019.01.022

[20] Hao, Q., Gudapati, V., Monsel, A., et al., 2019. Mesenchymal Stem Cell-Derived Extracellular Vesicles 4 Decrease Lung Injury in Mice. The Journal of Immunology. 203, 1961-1972.

[21] DOI: https://doi.org/10.4049/jimmunol.1801534

[22] Kaur, S.P., Gupta, V., 2020. COVID-19 Vaccine: A Comprehensive Status Report. Virus Research. 288, 198114. DOI: https://doi.org/10.1016/j.virusres.2020.198114

[23] Jeyanathan, M., Afkhami, S., Smaill, F., et al., 2020. Immunological Considerations for COVID-19 Vaccine Strategies. Nature Reviews Immunology. 20, 615-632.

[24] DOI: https://doi.org/10.1038/s41577-020-00434-6

[25] Jb, L.P., 2005. Dexosomes as a Therapeutic Cancer Vaccine: From Bench to Bedside. Blood Cells, Molecules & Diseases. 35. DOI: https://doi.org/10.1016/j.bcmd.2005.06.003

[26] Tan, A., De La Peña, H., Seifalian, A.M., 2010. The Application of Exosomes as a Nanoscale Cancer Vaccine. International Journal of Nanomedicine. 5, 889-900.

[27] DOI: https://doi.org/10.2147/IJN.S13402

[28] Kuate, S., Cinatl, J., Doerr, H.W., et al., 2007. Exosomal Vaccines Containing the S Protein of the SARS Coronavirus Induce High Levels of Neutralizing Antibodies. Virology. 362, 26.

[29] DOI: https://doi.org/10.1016/j.virol.2006.12.011

[30] Théry, C., Ostrowski, M., Segura, E., 2009. Membrane Vesicles as Conveyors of Immune Responses. Nature Reviews Immunology. 9, 581-593. DOI: https://doi.org/10.1038/nri2567

[31] Millar, J.E., Bahr, V.von., Malfertheiner, M.V., et al., 2019. Administration of Mesenchymal Stem Cells during ECMO Results in a Rapid Decline in Oxygenator Performance. Thorax. 74, 194-196,

[32] DOI: https://doi.org/10.1136/thoraxjnl-2017-211439